• Another Weight-Loss Trial Win for Weekly GLP-1 Drug

    1 month ago - By MedPageToday

    When paired with lifestyle management, once-weekly semaglutide yielded significant weight loss for overweight adults with type 2 diabetes, the manufacturer-sponsored Semaglutide Treatment Effect in People with Obesity...
    Read more ...

     

  • Azura MGD treatment meets primary endpoints in phase 2 trial

    Azura MGD treatment meets primary endpoints in phase 2 trial

    1 month ago - By Healio

    Significant improvement in signs and symptoms of meibomian gland dysfunction were achieved with AZR-MD-001, a topical ointment, thus meeting the primary endpoints of the drug's phase 2 trial, Azura Ophthalmics announced in a press release.
    In the multicenter, double-masked, vehicle-controlled, integrated analysis of four separate phase 2 studies, safety and efficacy of AZR-MD-001 were analyzed for doses of 0.1%, 0.5% and 1% in 95 patients.
    Statistically significant reduction of symptoms as measured by Ocular Surface Disease Index scores was demonstrated in the 0.5% and 1% groups (both P
    Read more ...